Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 626.00
+8.00 (1.29%)
May 26, 2026, 5:05 PM GMT
Oxford Biomedica Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Oxford Biomedica stock has a consensus rating of "Strong Buy" and an average price target of 843p. The average 1-year stock price forecast is 34.64% higher than the current stock price, while the lowest is 550p (-12.14%) and the highest is 1,170p (+86.90%).
Price Target: 843p (+34.64%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 24, 2026.
Analyst Ratings
The average analyst rating for Oxford Biomedica stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains 1,170p | Buy | Maintains | 1,170p | +86.90% | Mar 24, 2026 |
| Jefferies | Jefferies | Buy Maintains 827p | Buy | Maintains | 827p | +32.11% | Mar 23, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates 950p | Buy | Reiterates | 950p | +51.76% | Mar 11, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Upgrades 380p → 735p | Buy | Upgrades | 380p → 735p | +17.41% | Jan 6, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains 400p → 550p | Hold | Maintains | 400p → 550p | -12.14% | Dec 8, 2025 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.